Weiwei Gui

547 total citations
26 papers, 367 citations indexed

About

Weiwei Gui is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Weiwei Gui has authored 26 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Physiology. Recurrent topics in Weiwei Gui's work include Cancer-related molecular mechanisms research (8 papers), Adipose Tissue and Metabolism (6 papers) and MicroRNA in disease regulation (5 papers). Weiwei Gui is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Adipose Tissue and Metabolism (6 papers) and MicroRNA in disease regulation (5 papers). Weiwei Gui collaborates with scholars based in China. Weiwei Gui's co-authors include Xihua Lin, Hong Li, Yiyi Zhu, Fenping Zheng, Fang Wu, Fang Wu, Li Lin, Tingting Tao, Yiping Zhu and Shengjie Tang and has published in prestigious journals such as Diabetes, Experimental Cell Research and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Weiwei Gui

23 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Gui China 12 238 195 75 55 32 26 367
Yaping Zhao China 14 294 1.2× 182 0.9× 93 1.2× 50 0.9× 19 0.6× 21 436
Kyoko Tanimura Japan 9 193 0.8× 121 0.6× 54 0.7× 35 0.6× 46 1.4× 11 352
Satoshi Yamaguchi Japan 9 159 0.7× 130 0.7× 41 0.5× 84 1.5× 46 1.4× 29 338
Lei Kong China 4 303 1.3× 342 1.8× 51 0.7× 40 0.7× 36 1.1× 6 468
Wenfang Peng China 11 275 1.2× 257 1.3× 33 0.4× 45 0.8× 23 0.7× 23 435
Xiujie Liang China 11 144 0.6× 86 0.4× 32 0.4× 39 0.7× 19 0.6× 18 359
Yideng Jiang China 12 239 1.0× 114 0.6× 29 0.4× 36 0.7× 15 0.5× 25 401
Bartomeu Ruiz Spain 5 272 1.1× 233 1.2× 194 2.6× 122 2.2× 33 1.0× 6 486
Libing Hu China 9 230 1.0× 133 0.7× 32 0.4× 21 0.4× 23 0.7× 12 366
Minwen Xu China 8 198 0.8× 156 0.8× 36 0.5× 56 1.0× 32 1.0× 10 334

Countries citing papers authored by Weiwei Gui

Since Specialization
Citations

This map shows the geographic impact of Weiwei Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Gui more than expected).

Fields of papers citing papers by Weiwei Gui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Gui. The network helps show where Weiwei Gui may publish in the future.

Co-authorship network of co-authors of Weiwei Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Gui. A scholar is included among the top collaborators of Weiwei Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Gui. Weiwei Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gui, Weiwei, et al.. (2025). Paradoxical regulation of IGF2 in promoting lipid metabolism in adipose tissues. Communications Biology. 8(1). 1026–1026.
2.
Zhou, Caiping, Weiwei Gui, Fengbin Zhang, et al.. (2024). Correlation of IGF2 levels with sperm quality, inflammation, and DNA damage in infertile patients. Asian Journal of Andrology. 27(2). 204–210. 2 indexed citations
3.
4.
Zhou, Xiaohai, et al.. (2023). IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling in d-galactose-induced aging mice. Molecular Medicine. 29(1). 161–161. 8 indexed citations
5.
Zhang, Ziming, Weiwei Gui, Zheng Shen, et al.. (2022). Identification of the Key Pathways and Genes in Hypoxia Pulmonary Arterial Hypertension Following Intrauterine Growth Retardation. Frontiers in Molecular Biosciences. 9. 789736–789736. 1 indexed citations
6.
Lin, Xihua, et al.. (2022). Association of genetic variants in the Sirt1 and Nrf2 genes with the risk of metabolic syndrome in a Chinese Han population. BMC Endocrine Disorders. 22(1). 84–84. 7 indexed citations
7.
Zhu, Yiping, et al.. (2022). Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (PVT1) in human diseases. Genes & Diseases. 10(3). 901–914. 14 indexed citations
8.
Wu, Beibei, et al.. (2021). Transthyretin contributes to insulin resistance and diminishes exercise-induced insulin sensitivity in obese mice by inhibiting AMPK activity in skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism. 320(4). E808–E821. 8 indexed citations
9.
Gui, Weiwei, et al.. (2021). Association of Genetic Variants in IGF2-Related Genes With Risk of Metabolic Syndrome in the Chinese Han Population. Frontiers in Endocrinology. 12. 654747–654747. 5 indexed citations
10.
Zhu, Yiping, Fang Wu, Weiwei Gui, et al.. (2021). A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1α in pancreatic cancer. Journal of Molecular Cell Biology. 13(9). 676–689. 21 indexed citations
11.
Lin, Xihua, Ying Du, Weina Lu, et al.. (2021). CircRNF111 Protects Against Insulin Resistance and Lipid Deposition via Regulating miR-143-3p/IGF2R Axis in Metabolic Syndrome. Frontiers in Cell and Developmental Biology. 9. 663148–663148. 22 indexed citations
12.
Gui, Weiwei, et al.. (2020). Platelet to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer undergoing palliative treatment. Annals of Palliative Medicine. 9(5). 3271–3277. 11 indexed citations
13.
14.
Tang, Shengjie, Fenping Zheng, Weiwei Gui, et al.. (2020). <p>The Long Noncoding RNA Blnc1 Protects Against Diet-Induced Obesity by Promoting Mitochondrial Function in White Fat</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1189–1201. 16 indexed citations
15.
Gui, Weiwei, et al.. (2020). Retrospective analysis of different regimens for Chinese adults with severe newly diagnosed immune thrombocytopenia. Clinical and Experimental Medicine. 20(3). 381–385. 6 indexed citations
16.
Zhang, Ziyi, Shengjie Tang, Weiwei Gui, et al.. (2020). Liver X receptor activation induces podocyte injury via inhibiting autophagic activity. Journal of Physiology and Biochemistry. 76(2). 317–328. 14 indexed citations
17.
Gui, Weiwei, Wei Zhu, Yiyi Zhu, et al.. (2020). LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1. Cell Communication and Signaling. 18(1). 173–173. 28 indexed citations
18.
Gui, Weiwei, et al.. (2020). Maternal undernutrition modulates hepatic MicroRNAs expression in the early life of offspring. Experimental Cell Research. 400(2). 112450–112450. 8 indexed citations
19.
Zhu, Yiyi, Weiwei Gui, Xihua Lin, & Hong Li. (2019). Knock-down of circular RNA H19 induces human adipose-derived stem cells adipogenic differentiation via a mechanism involving the polypyrimidine tract-binding protein 1. Experimental Cell Research. 387(2). 111753–111753. 71 indexed citations
20.
Lin, Xihua, Weiwei Gui, Tingting Tao, et al.. (2018). Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor. Translational research. 205. 33–43. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaping Zhao Breakdown of academic impact, for papers by Kyoko Tanimura Breakdown of academic impact, for papers by Satoshi Yamaguchi Breakdown of academic impact, for papers by Lei Kong Breakdown of academic impact, for papers by Wenfang Peng Breakdown of academic impact, for papers by Xiujie Liang Breakdown of academic impact, for papers by Yideng Jiang Breakdown of academic impact, for papers by Bartomeu Ruiz Breakdown of academic impact, for papers by Libing Hu Breakdown of academic impact, for papers by Minwen Xu
Rankless by CCL
2026